Northrop Grumman Corporation
584.99-10.06 (-1.69%)
Oct 29, 4:00:02 PM EDT · NYSE · NOC · USD
Key Stats
Market Cap
83.49BP/E (TTM)
21.05Basic EPS (TTM)
27.79Dividend Yield
0.01%Recent Filings
10-Q
Q3 FY2025 results
Northrop Grumman posted solid Q3 results, with sales climbing 4% year-over-year to $10.4B, fueled by gains in Mission Systems and Defense Systems, though Space Systems dipped amid program wind-downs. Operating income rose 11% to $1.2B, lifting the margin to 11.9% on better contract performance and efficiencies, while diluted EPS hit $7.67, up 10%. Year-to-date, sales held steady at $30.2B but operating income slipped 1% to $3.2B, pressured by a $477M B-21 loss provision in Q1, offset by a $231M gain from divesting the training services unit in May for $333M cash. Cash dipped to $2.0B amid $860M operating cash flow and $1.2B share repurchases, with $15.7B total debt and full $3.0B revolver availability. Free cash flow tallied $72M after $788M capex. Backlog stayed robust at $91.4B. Yet regulatory probes into pension accounting assumptions pose ongoing scrutiny.
8-K
Q3 sales rise 4%
Northrop Grumman posted third-quarter 2025 sales of $10.4 billion, up 4% from last year, fueled by robust gains in Mission Systems and Defense Systems while Space Systems dipped on program wind-downs. Operating margin hit 11.9%, with diluted EPS climbing 10% to $7.67 amid strong segment performance. The company boosted its full-year MTM-adjusted EPS guidance to $25.65–$26.05, signaling confidence in sustained demand. Backlog holds steady at $91.4 billion. Momentum builds.
8-K
Northrop Grumman ups credit line
Northrop Grumman secured a $3 billion five-year revolving credit facility on September 2, 2025, up from its prior $2.5 billion line, to back its commercial paper program and general corporate needs. The deal, led by JPMorgan Chase, imposes a 65% debt-to-capitalization cap while allowing asset sales and mergers with exceptions. Lenders hold sway through standard defaults like nonpayment or change of control. Yet liquidity stays tight.
8-K
Q2 sales up 1%, guidance raised
Northrop Grumman posted Q2 2025 sales of $10.4 billion, up 1% from last year, fueled by 14% growth in Mission Systems yet dragged by 12% drop in Space Systems from program wind-downs. Net earnings hit $1.2 billion, or $8.15 diluted EPS, boosted by a $231 million gain from divesting its training services business. The company raised full-year guidance, lifting segment operating income to $4.275-$4.375 billion and MTM-adjusted EPS to $25.00-$25.40. Backlog stands at $89.7 billion. Solid execution shines through.
10-Q
Q2 FY2025 results
Northrop Grumman posted solid Q2 results, with sales up 1% year-over-year to $10.4B, driven by gains in Mission Systems and Defense Systems that offset a 12% drop in Space Systems from program wind-downs. Operating income surged 31% to $1.4B, boosted by a $231M gain from selling the training services unit in May for $333M cash, while margins hit 13.8% amid better contract performance. Year-to-date, sales dipped 3% to $19.8B and net earnings fell 12% to $1.7B, pressured by a $477M B-21 loss provision, yet diluted EPS held at $11.45 on share buybacks. Cash dipped to $1.9B after $697M operating outflow, but $89.7B backlog signals steady demand. Free cash flow turned negative at -$1.2B, with $15.7B long-term debt steady. The divestiture sharpened focus on core defense tech. Yet regulatory scrutiny on pension accounting assumptions looms large.
IPO
Employees
Sector
Industry
AVAV
AeroVironment, Inc.
380.65+0.72
BA
Boeing Company (The)
213.58-9.75
BAESF
BAE Systems PLC
24.90+0.05
CW
Curtiss-Wright Corporation
601.63+13.20
DRS
Leonardo DRS, Inc.
38.43-1.75
GD
General Dynamics Corporation
343.48-3.20
GE
GE Aerospace
314.28+4.49
KTOS
Kratos Defense & Security Solut
91.21+1.43
LMT
Lockheed Martin Corporation
485.33-0.44
RTX
RTX Corporation
176.36-2.31